Cheng San Brian Chia

16PUBLICATIONS
6CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsProteins and peptidesPredictive and prognostic markersPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 07, 2025
Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity.

Qian Wen Tan, Subramanyam Vankadara, Jia Yi Fong

|Apr 15, 2024
Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D-Cys6-LHRH vedotin, against ovarian cancer cell lines.

Subramanyam Vankadara, Zhiyuan Ke, Sifang Wang

|May 29, 2023
A Patent Review on SARS Coronavirus Papain-Like Protease (PLpro ) Inhibitors.

C S Brian Chia, Siew Pheng Lim

|Jan 19, 2023
Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer.

C S Brian Chia

|Sep 15, 2022
Novel Coronavirus Main Protease Di- and Tripeptide Inhibitors for Treating COVID-19.

C S Brian Chia, Yi Yang See

|Sep 15, 2022
Oral Nonpeptidic, Noncovalent Triazine Coronavirus Main Protease Inhibitors for Treating COVID-19.

C S Brian Chia, Masafumi Inoue

Pageof 3

Frequent Collaborators

2 joint publications

Pearly Shuyi Ng

2 joint publications

Weijun Xu

2 joint publications

Chuhui Huang

2 joint publications

Shu Ting Tan